ProFound AI: Conquering New Frontiers of Cancer Detection and Therapy
iCAD, Inc. (NASDAQ: ICAD), a premier medical technology Company providing cutting-edge cancer detection and therapy solution, presented new research supporting ProFound AI platform, an FDA-cleared, CE marked world-class AI powered breast health solution that is revolutionizing screening and detection of breast cancers. The Company also...
